A renowned physician-scientist says treatment is not one-size-fits-all.

Switching off a single enzyme in immune cells protected mice from obesity, type 2 diabetes, and fatty liver disease in a new study, offering a potential new treatment target for metabolic disorders.

Obesity is when your BMI is 30 or higher. Obesity is split into three classes based on BMI levels. Health problems like high blood pressure and diabetes can result from obesity. Obesity is broadly ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The risk for type 2 diabetes is more than two times ...

The prevalence of type 2 diabetes and obesity worldwide is increasing, and these two conditions have a bidirectional and linear relationship. Obesity worsens the development of type 2 diabetes by ...

A recent study adds one more reason to be concerned about obesity in adolescents and young adults. A research letter, published online in JAMA Pediatrics in August, found that large portions of ...

In a recent study published in Nature, a team of scientists examined how adipose tissue, specifically fat cells, retains transcriptional changes even after significant weight loss, potentially leading ...

A once-weekly injectable GIP/GLP-1 dual agonist conferred up to 22.5% weight loss at 48 weeks for adults with overweight or ...

GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are ...

The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study. Blocking ...